Results of subgroup analyses performed in our cohort that found similar frequencies of Parkinsonism and antipsychotic use in patients with and without dopamine deficiency on DAT-Scan (Table S1) support these conclusions. The gene discussed is SLC6A3; the disease is Parkinsonism.